• *** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know
N/A
Please sign in first
none
none
none
| Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
|---|---|---|---|---|
|
No longer subject to file | 2009-09-14 | 0 | |
|
PRESIDIO MANAGEMENT GROUP VIII L L C USVP ENTREPRENEUR PARTNERS VIII A L P USVP ENTREPRENEUR PARTNERS VIII B L P CONNORS TIMOTHY J |
|
No longer subject to file | 2009-09-14 | 0 |
|
0 | 2009-07-01 | 0 | |
|
0 | 2009-07-01 | 0 | |
|
0 | 2009-07-01 | 0 | |
|
0 | 2009-07-01 | 0 | |
|
0 | 2009-07-01 | 0 | |
|
No longer subject to file | 2009-04-16 | 0 | |
|
GEMAYEL GEORGES PRESIDENT & CEO |
|
0 | 2009-02-19 | 0 |
|
GOTWALS PHILIP VP, PROGRAM MANAGEMENT |
|
0 | 2009-01-27 | 0 |
|
PHAIR THOMAS J. SR. DIR, FINANCE & CONTROLLER |
|
0 | 2009-01-27 | 0 |
|
ATTIE KENNETH VP, CLINICAL DEV & MED AFFAIRS |
|
0 | 2009-01-27 | 0 |
|
PORTER JILL VP, PROCESS DEV & ENGINEERING |
|
0 | 2009-01-27 | 0 |
|
HEN STEWART |
|
0 | 2008-06-12 | 0 |
|
0 | 2008-06-12 | 0 | |
|
0 | 2008-06-12 | 0 | |
|
BLANK BURKHARD EVP & CHIEF MEDICAL OFFICER |
|
0 | 2008-05-22 | 0 |
|
LIEBER JONATHAN I SVP, CFO AND TREASURER |
|
0 | 2008-05-22 | 0 |
|
BERKLE SHELDON PRESIDENT AND CEO |
|
479,152 | 2007-12-13 | 0 |
|
GALLOTTO ROBERT VP, STRATEGIC PLANNING |
|
28,822 | 2007-11-01 | 0 |
|
MARGOLIN ALEXEY L CHIEF SCIENTIFIC OFFICER |
|
135,204 | 2007-07-18 | 0 |
|
3,260,770 | 2006-01-31 | 0 | |
|
NOMURA PHASE4 VENTURES LP NOMURA PHASE4 VENTURES LTD NOMURA PHASE4 VENTURES GP LTD |
|
1,956,962 | 2006-01-31 | 0 |
|
NOMURA PHASE4 VENTURES LP |
|
1,956,998 | 2006-01-31 | 0 |
|
817,749 | 2006-01-31 | 0 | |
|
0 | 2006-01-25 | 0 |
| Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| No current insider transactions | ||||||||||||||||
* -
| Code | Definition |
|---|---|
| A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
| C | Conversion of derivative security |
| D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
| G | Bona fide gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
| J | Other acquisition or disposition |
| L | Small acquisition under Rule 16a-6 |
| M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
| O | Exercise of out-of-the-money derivative security |
| P | Open market or private purchase of non-derivative or derivative security |
| S | Open market or private sale of non-derivative or derivative security |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| W | Acquisition or disposition by will or the laws of descent and distribution |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
| Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
|---|
| Holder | Issuer | Net Short Position | Position Date | Origin |
|---|
